Retatrutide works as a powerful triple-agonist, meaning it works on on three key hormone receptors: The human glucagon receptor (GCGR) The glucose-dependent polypeptide receptor (GIP receptor) The glucagon-like peptide-1 receptor (GLP-1) This unique receptor profile allows retatrutide to effectively: Regulate appetite, feelings of fullness, and gastric emptying Regulate metabolism Regulate blood sugar levels The activation of the GIP, GLP-1, and GCG receptors simultaneously by retatrutide leads to better weight loss and cardiometabolic benefits compared to targeting a single receptor
At AgeRejuvenation, cagrilintide is prescribed inside a supervised metabolic plan, never as a standalone shortcut
Qualifying for Wegovy Wegovy is FDA-approved specifically for weight loss
They are drugs that mimic the gut hormone GLP-1 to lower blood sugar and reduce appetite
10.3390/nu15102299 88 GeorgeT
In California, the penalties under the labor code for misclassification are particularly significant